Compare VKQ & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VKQ | MLAB |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 535.6M | 593.4M |
| IPO Year | 1994 | 1995 |
| Metric | VKQ | MLAB |
|---|---|---|
| Price | $9.69 | $123.72 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $94.00 |
| AVG Volume (30 Days) | ★ 164.7K | 137.8K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.07 |
| Revenue Next Year | N/A | $5.41 |
| P/E Ratio | ★ N/A | $243.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.04 | $59.63 |
| 52 Week High | $10.11 | $121.90 |
| Indicator | VKQ | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 38.01 | 71.24 |
| Support Level | $9.68 | $94.20 |
| Resistance Level | $9.82 | N/A |
| Average True Range (ATR) | 0.08 | 6.22 |
| MACD | -0.01 | 1.79 |
| Stochastic Oscillator | 4.84 | 99.88 |
Invesco Municipal Trust is a diversified, closed-end management investment company. The company's investment objective is to provide a high level of current income exempt from federal income tax, consistent with the preservation of capital.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.